|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 50 of 52 found articles
| Title: |
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study |
| Author: |
Rimassa, Lorenza Assenat, Eric Peck-Radosavljevic, Markus Pracht, Marc Zagonel, Vittorina Mathurin, Philippe Rota Caremoli, Elena Porta, Camillo Daniele, Bruno Bolondi, Luigi Mazzaferro, Vincenzo Harris, William Damjanov, Nevena Pastorelli, Davide Reig, María Knox, Jennifer Negri, Francesca Trojan, Jörg López López, Carlos Personeni, Nicola Decaens, Thomas Dupuy, Marie Sieghart, Wolfgang Abbadessa, Giovanni Schwartz, Brian Lamar, Maria Goldberg, Terri Shuster, Dale Santoro, Armando Bruix, Jordi |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 19 (2018) nr. 5 pages 682-693 |
| Year: |
2018 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 50 of 52 found articles
| << previous | next >> |